Maharashtra FDA fully in compliance with DCGI order (PharmaBiz) The
Maharashtra FDA fully in compliance with DCGI order (PharmaBiz)
The DCGI's invocation of section 33 (p) of Drugs & Cosmetic Acts, which is binding on the state drug authorities, will not have much effect in Maharashtra as the state Food and Drug Administration (FDA) has fully complied with the DCGI order well before the latest Madras High Court order which prompted the DCGI to invoke section 33 (p).
CellSearch Circulating Tumor Cell Kit Receives FDA Clearance For Monitoring Patients With Metastatic Colorectal Cancer (Medical News Today)
Immunicon Corporation (NASDAQ-GM:IMMC) announced that FDA clearance has been received for the CellSearch Circulating Tumor Cell Kit as an aid in the monitoring of patients with metastatic colorectal cancer. The CellSearch test was originally cleared in 2004 for in vitro diagnostic use in patients with metastatic breast cancer. [click link for full article]